AlphaMark Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-17
| Closed | -$2K | – | 773 |
|
|
2023
Q4 | $2K | Sell |
17
-50
| -75% | -$5.88K | ﹤0.01% | 657 |
|
|
2023
Q3 | $7K | Buy |
67
+17
| +34% | +$1.78K | ﹤0.01% | 557 |
|
|
2023
Q2 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 468 |
|
|
2023
Q1 | – | Sell |
-75
| Closed | -$13K | – | 643 |
|
|
2022
Q4 | $13K | Hold |
75
| – | – | 0.01% | 342 |
|
|
2022
Q3 | $9K | Hold |
75
| – | – | ﹤0.01% | 431 |
|
|
2022
Q2 | $11K | Sell |
75
-200
| -73% | -$29.3K | 0.01% | 384 |
|
|
2022
Q1 | $47K | Sell |
275
-140
| -34% | -$23.9K | 0.02% | 234 |
|
|
2021
Q4 | $105K | Buy |
415
+64
| +18% | +$16.2K | 0.04% | 184 |
|
|
2021
Q3 | $135K | Buy |
351
+1
| +0.3% | +$385 | 0.05% | 164 |
|
|
2021
Q2 | $82K | Sell |
350
-175
| -33% | -$41K | 0.03% | 195 |
|
|
2021
Q1 | $69K | Sell |
525
-220
| -30% | -$28.9K | 0.03% | 202 |
|
|
2020
Q4 | $78K | Buy |
745
+645
| +645% | +$67.5K | 0.03% | 180 |
|
|
2020
Q3 | $7K | Buy |
100
+60
| +150% | +$4.2K | ﹤0.01% | 407 |
|
|
2020
Q2 | $3K | Buy |
+40
| New | +$3K | ﹤0.01% | 471 |
|